The Health Pulse S3E7: The future of clinical trial recruitment is digital, and patients are the biggest winners
Dr. Tobias Kruse shares how his company is filling a gap for digitalization in clinical trial patient recruitment and why patients and sponsors are benefitting.
Tobias Kruse never dreamed of being an entrepreneur. He recognized a problem he knew he could solve and founded the clinical trial recruitment company Trials24, where he is now CEO.
On this episode, Kruse shares his company’s inception story with Alex. As a young scientist working on a clinical trial, Kruse realized that dated, print-based patient recruitment tactics weren’t working. He had learned a thing or two about online marketing from one of his side hustles and decided to take a leap. He launched Trials24 to digitalize patient recruitment and to speed up drug development timelines. The company’s digital-first approach helps address the lack of diversity in clinical research by targeting awareness campaigns to underserved communities and recruiting more diverse populations for clinical trials.
Kruse knows digitalization is the future of patient recruitment, bringing better patient experiences and more representative clinical trials.
All presentations represent the opinions of the presenter and do not represent the position or the opinion of SAS.
On this episode, Kruse shares his company’s inception story with Alex. As a young scientist working on a clinical trial, Kruse realized that dated, print-based patient recruitment tactics weren’t working. He had learned a thing or two about online marketing from one of his side hustles and decided to take a leap. He launched Trials24 to digitalize patient recruitment and to speed up drug development timelines. The company’s digital-first approach helps address the lack of diversity in clinical research by targeting awareness campaigns to underserved communities and recruiting more diverse populations for clinical trials.
Kruse knows digitalization is the future of patient recruitment, bringing better patient experiences and more representative clinical trials.
All presentations represent the opinions of the presenter and do not represent the position or the opinion of SAS.
